Dublin, Feb. 21, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.
The report includes profiles of 137 companies involved in sequencing and their 147 collaborations. The report text is supplementd by 42 tables, 21 figures and 500 selected references to the literature.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer.
Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2015 is described with estimates for 2020 and 2025. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
Key Topics Covered:
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
15. References
For more information about this report visit http://www.researchandmarkets.com/research/365sfm/dna_sequencing
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 



